Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$831K Buy
+8,210
New +$940K 0.01% 209
2021
Q1
– Sell
-3,384
Closed -$344K – 890
2020
Q4
$344K Sell
3,384
-32,461
-91% -$3.05M 0.01% 439
2020
Q3
$3.02M Sell
35,845
-10,204
-22% -$794K 0.06% 95
2020
Q2
$2.99M Sell
46,049
-29,313
-39% -$1.93M 0.06% 103
2020
Q1
$4.91M Sell
75,362
-23,048
-23% -$1.82M 0.1% 82
2019
Q4
$7.75M Buy
98,410
+20,314
+26% +$1.58M 0.11% 75
2019
Q3
$6.22M Buy
+78,096
New +$6.14M 0.09% 99

Other funds holding XYL

Lee Ainslie's XYL Position: Q3 2026 in Review

Lee Ainslie opened a new position in Xylem (XYL) in Q3 2026: 8,210 shares worth $831K. The stake represents 0.01% of the portfolio and ranks #209 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in XYL as recently as Q4 2020.

Lee Ainslie first reported a position in XYL in Q3 2019 and has held it in 7 quarters since. The position peaked at $7.75M in Q4 2019. 1,059 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • Lee Ainslie held 8,210 shares of Xylem worth $831K as of Q3 2026.
  • Xylem was a new Lee Ainslie position in Q3 2026.
  • Xylem made up 0.01% of Lee Ainslie's portfolio in Q3 2026, its #209 holding.
  • Lee Ainslie first reported a position in Xylem in Q3 2019 and has held it in 7 quarters since.
  • Lee Ainslie's Xylem position peaked at $7.75M in Q4 2019.
  • 1,059 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.